Evidence map›Paper›PMID 40141402›Full record

ArticleInternational journal of molecular sciences2025

Central Serotonin Deficiency Impairs Recovery of Sensorimotor Abilities After Spinal Cord Injury in Rats.

Yuri I Sysoev, Polina Y Shkorbatova, Veronika A Prikhodko, Daria S Kalinina, Elena Y Bazhenova, Sergey V Okovityi, Michael Bader, Natalia Alenina, Raul R Gainetdinov, Pavel E Musienko

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The Effect of L-Tryptophan Intake on Dynamic Strength in Paralympic Powerlifting.International journal of tryptophan research : IJTR · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuri I SysoevDepartment of Neuroscience, Sirius University of Science and Technology, Sirius 353340, Russia.
Polina Y ShkorbatovaPavlov Institute of Physiology of the RAS, Saint Petersburg 199034, Russia.ORCID 0000-0001-5777-7775
Veronika A PrikhodkoDepartment of Pharmacology and Clinical Pharmacology, Saint Petersburg State Chemical and Pharmaceutical University, Saint Petersburg 197022, Russia.ORCID 0000-0002-4690-1811
Daria S KalininaDepartment of Neuroscience, Sirius University of Science and Technology, Sirius 353340, Russia.
Elena Y BazhenovaPavlov Institute of Physiology of the RAS, Saint Petersburg 199034, Russia.
Sergey V OkovityiDepartment of Pharmacology and Clinical Pharmacology, Saint Petersburg State Chemical and Pharmaceutical University, Saint Petersburg 197022, Russia.ORCID 0000-0003-4294-5531
Michael BaderMax Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.
Natalia AleninaMax Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.ORCID 0000-0002-6071-5433
Raul R GainetdinovInstitute of Translational Biomedicine, Saint Petersburg State University, 7-9 Universitetskaya Emb., Saint Petersburg 199034, Russia.
Pavel E MusienkoDepartment of Neuroscience, Sirius University of Science and Technology, Sirius 353340, Russia.

Funding

grant of the state program of the «Sirius» Federal Territory «Scientific and technological development of the «Sirius» Federal Territory» (Agreement №18-03 date 10.09.2024).
6 · The paper itself

Abstract

Spinal cord injury (SCI) affects millions of people worldwide. One of the main challenges of rehabilitation strategies is re-training and enhancing the plasticity of the spinal circuitry that was preserved or rebuilt after the injury. The serotonergic system appears to be crucial in these processes, since recent studies have reported the capability of serotonergic (5-HT) axons for axonal sprouting and regeneration in response to central nervous system (CNS) trauma or neurodegeneration. We took advantage of tryptophan hydroxylase 2 knockout (TPH2 KO) rats, lacking serotonin specifically in the brain and spinal cord, to study the role of the serotonergic system in the recovery of sensorimotor function after SCI. In the present work, we compared the rate of sensorimotor recovery of TPH2 KO and wild-type (WT) female rats after SCI (lateral hemisection at the T8 spinal level). SCI caused severe motor impairments in the ipsilateral left hindlimb, the most pronounced in the first week after the hemisection with gradual functional recovery during the following 3 weeks. The results demonstrate that TPH2 KO rats have less potential to recover motor functions since the degree of sensorimotor deficit in the tapered beam walking test (TBW) and ladder walking test (LW) was significantly higher in the TPH2 KO group in comparison to the WT animals in the 3rd and 4th weeks after SCI. The recovery dynamics of the hindlimb muscle tone and voluntary movements was in agreement with the restoration of motor performance in TBW and LW. Compound muscle action potential analysis in the gastrocnemius (GM) and tibialis (TA) muscles of both hindlimbs after electrical stimulation of the sciatic nerve or lumbar region (L5-L6) of the spinal cord indicated slower recovery of sensorimotor pathways in the TPH2 KO group versus their WT counterparts. In general, the observed results confirm the significance of central serotonergic mechanisms in the recovery of sensorimotor functions in rats and the relevance of the TPH2 KO rat model in studying the role of the 5-HT system in neurorehabilitation.

Indexed as

Recovery of FunctionSerotoninSpinal Cord InjuriesTryptophan HydroxylaseAnimalsDisease Models, AnimalFemaleRatsSpinal CordSerotonintph2 protein, ratTryptophan Hydroxylasecompound muscle action potentialladder walking testlateral hemisectionsensorimotor functionserotoninspinal cord injurystatic rodtapered beam walking testTPH2

Identifiers

PMID40141402
PMCPMC11942851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.